Tilray Brands Inc
Q4 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +2.15%.
Did TLRY Beat Earnings? Q4 2025 Results
Tilray Brands delivered a notably mixed but strategically coherent quarter, posting <a href="https://247wallst.com/investing/2025/07/28/earnings-live-complete-tilray-brands-tlry-4q-coverage/">Q4 fiscal 2025 results</a> that beat analyst expectations on the bottom line even as revenue fell sharply year over year. The company earned $0.02 per share against a consensus estimate of -$0.02, a 200.00% beat, while revenue of $224.53 million reflected a 28.3% decline from the prior-year period, weighed down by deliberate strategic tradeoffs including the exit from lower-margin vape categories and wholesale channels that together shaved roughly $35.00 million from the top line. The most material driver of the result was a $1.40 billion non-cash goodwill impairment tied to assets originally recorded during the 2021 Aphria-Tilray merger, which dominated the GAAP loss but left adjusted EBITDA of $27.64 million intact, described by management as the second-highest quarterly figure in company history. Those same strategic pivots helped expand global cannabis gross margin by 700 basis points to 40% for the full year. Looking ahead, Tilray guided fiscal 2026 adjusted EBITDA of $62.00 million to $72.00 million, representing 13% to 31% growth, anchored by international cannabis expansion and continued beverage integration synergies.
- International cannabis revenue increased 71% in Q4, driven by redirecting Canadian inventory to higher-margin international markets
- Global cannabis gross margin expanded by 700 basis points in fiscal 2025 through strategic pricing and category mix optimization
- Acquisition of four Molson Coors craft brands (Hop Valley, Terrapin, Revolver, Atwater) drove 19% beverage revenue growth for fiscal year
- Project 420 integration initiative realized $24 million in annualized savings toward $33 million target
- Approximately $100 million in total debt repayments, bringing net debt to adjusted EBITDA to 0.3x
“In Fiscal Year 2025, we meaningfully advanced our platform, driving growth in all of our sectors, cannabis, beverage, and wellness. Our progress is rooted in a deep understanding of evolving consumer needs, shaping offerings that not only reflect, but anticipate how people choose to eat, drink, relax, and address their wellbeing. We increased revenue, enhanced efficiency, and boosted gross profit across all our businesses. Our continued investment in growth led to record fiscal year revenue, underscoring the resilience and durability of our strategy.”
Tilray Brands CEO, on the earnings call
Forward Guidance & Outlook
For fiscal year 2026 (ending May 31, 2026), Tilray expects adjusted EBITDA of $62 million to $72 million, representing growth of 13% to 31% compared to fiscal year 2025. The company sees key growth opportunities in international cannabis (particularly Europe, Middle East, India, Türkiye, and Asia), continued beverage integration synergies from Project 420 with completion of the synergy optimization plan anticipated in Q3 FY2026, and expansion of hemp-derived Delta-9 THC beverages in the U.S. Tilray plans to enhance its global supply chain through Phase II of its accelerated growth plan and increase cultivation footprint to support growing Canadian and international demand.
TLRY YoY Financials
TLRY Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.